Dermatomyositis is a rare inflammatory disease with characteristic cutaneous findings and
varying amounts of systemic involvement. Patients may present with skin disease alone …

Interstitial lung disease (ILD) is one of the most serious pulmonary complications of
connective tissue diseases (CTDs) and it is characterized by a deep impact on morbidity and …

Objectives The study aimed to develop evidence-based recommendations for the treatment
of rapidly progressive interstitial lung disease (RPILD) associated with the anti-Melanoma …

Objective: This study was conducted to identify the characteristics and prognosis of rapidly
progressive interstitial lung disease (RP-ILD) in idiopathic inflammatory myopathy (IIM) and …

Idiopathic inflammatory myopathies are autoimmune processes that are characterized by
skeletal muscle inflammation. The lung is the most commonly involved extramuscular organ …

Objectives To evaluate the efficacy and safety of ultra-low dose (100 mg) rituximab (RTX)
administration in anti-melanoma differentiation-associated gene 5 (MDA5) positive patients …

Objectives JDM and juvenile overlap myositis represent heterogeneous subtypes of juvenile
idiopathic inflammatory myopathy (JIIM). Chronic evolution can occur in up to 60% of cases …

Anti‐melanoma differentiation‐associated gene 5 (MDA5) antibody (Ab) is myositis‐specific
autoantibody associated with rapidly progressive interstitial lung disease (ILD) and poor …

Introduction: Dermatomyositis (DM) is characterized by skin lesions, such as heliotrope rash
and Gottron's papules/sign, and skeletal myopathy. Patients with DM often have arthritis …

The genetic differences in the myositis-susceptible loci may explain the heterogeneous
phenotypes and treatment responses in myositis-associated ILD. The understanding of …